baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Goldman Sachs Knock-Out LLY/ DE000GG1ZYV6 /

2024-08-02 11:00:47 AM	Chg.+0.95	Bid10:00:35 PM	Ask10:00:35 PM	Underlying	Strike price	Expiration date	Option type
18.47EUR	+5.42%	- Bid Size: -	- Ask Size: -	Eli Lilly and Co	616.9172 USD	2078-12-31	Call

TeleTrader 07-08 Eli Lilly launches $3.2B tender offer for Morphic

TeleTrader 07-02 US FDA approves Eli Lilly's Alzheimer's drug

GlobeNewswire 07-01 Ovid Therapeutics and Graviton Bioscience Announce Topline Data from a Phase 1 Clinical Trial Studyi...

GlobeNewswire 06-28 Atossa Therapeutics Announces Updated Protocol for Clinical Trial Evaluating (Z)-Endoxifen in Combin...

TeleTrader 06-25 Lilly partners with OpenAI to combat drug-resistance bacteria

GlobeNewswire 06-21 HUTCHMED Announces European Commission Approval for FRUZAQLA® (fruquintinib) Received by Takeda

GlobeNewswire 06-17 CytomX Therapeutics Promotes Chris Ogden to Chief Financial Officer

GlobeNewswire 06-17 Atossa Set to Join Russell 3000® Index Effective June 28, 2024

GlobeNewswire 06-14 TScan Therapeutics Announces Updates to its Board of Directors

GlobeNewswire 06-11 Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D ...

TeleTrader 06-10 FDA advisors endorse Eli Lilly's Alzheimer's drug

GlobeNewswire 06-10 Sermonix Pharmaceuticals Announces Breast Cancer Research Publication of Paper Examining Lasofoxifen...

GlobeNewswire 06-06 Sermonix Pharmaceuticals Announces Chinese Approval of Investigational New Drug Application for Laso...

TeleTrader 06-05 Alphabet appoints Anat Ashkenazi as new CFO

GlobeNewswire 06-03 HUTCHMED Highlights Publication of Phase III FRUTIGA Results in Nature Medicine

GlobeNewswire 05-30 Sermonix Pharmaceuticals to Present Poster on ELAINE-3 Trial in Progress at ASCO 2024

GlobeNewswire 05-30 Anaqua Annual User Experience Conference to Feature Keynotes from Microsoft, SAP, USPTO, and More

GlobeNewswire 05-24 Gov. Holcomb Joins Lilly to Announce Additional $5.3 Billion Investment at LEAP District

TeleTrader 05-24 Eli Lilly to reveal $5.3B production boost

TeleTrader 05-21 Eli Lilly's diabetes drug receives authorization in China

GlobeNewswire 05-16 BeyondSpring R&D Day Highlights New Plinabulin Development Strategy for Cancer and Updates for SEED ...

GlobeNewswire 05-16 Totus Medicines Announces Strategic Multi-Target Research Collaboration with Lilly

GlobeNewswire 05-13 Atossa Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire 05-13 Lycia Therapeutics Completes $106.6 Million Series C Financing to Advance Pipeline of LYTAC Extracel...

GlobeNewswire 05-09 ProQR Announces First Quarter 2024 Operating and Financial Results

Goldman Sachs Knock-Out LLY/ DE000GG1ZYV6 /

If you wish to receive reply to your feedback, please provide your email address.